ERCC1 expression and activity of PELF regimen as first-line treatment of metastatic gastric cancer patients

Autor:	D. Padalino, Fabrizio Nelli, M.G. Chilelli, Enzo Maria Ruggeri, T.V. Ranalli, V. Gomes, G. Natoli, Luca Moscetti, D. Giuliana, D. Arduini
Rok vydání:	2010
Předmět:	Cisplatin Oncology Cancer Research Chemotherapy medicine.medical_specialty business.industry medicine.medical_treatment PELF Regimen Metastatic gastric cancer First line treatment Internal medicine medicine ERCC1 business medicine.drug Nucleotide excision repair
Zdroj:	Journal of Clinical Oncology. 28:e14603-e14603
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2010.28.15_suppl.e14603
Popis:	e14603 Background: The role of the excision repair cross-complementing 1 (ERCC1) is well documented in a large number of tumor types with cisplatin-based chemotherapy. The aim of this study was to ...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5a603aec36f7ae608522e9994db15c85 https://doi.org/10.1200/jco.2010.28.15_suppl.e14603 Zobrazit plný text záznamu